Biological therapies are available for the treatment of the severe allergic asthma (SAA) with blood eosinophil count ≥ 0.3 × 10/L. Several of them also showed benefits on nasal polyps (NP), one of the most frequent comorbidities of the severe asthma, but comparative studies on their effectiveness in the association SAA-NP are currently lacking.
View Article and Find Full Text PDFInt J Environ Res Public Health
January 2021
: Tobacco smoking is associated with more severe asthma symptoms, an accelerated decline in lung function, and reduced responses to corticosteroids. Our objective was to compare asthma outcomes in terms of disease control, exacerbation rates, and lung function in a population of asthmatic patients according to their smoking status. : We compared patients' demographics, disease characteristics, and lung-function parameters in current-smokers (CS, = 48), former-smokers (FS, = 38), and never-smokers (NS, = 90), and identified predictive factors for asthma control.
View Article and Find Full Text PDF